(Q44919280)

7 December 2017

title

Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines (English)

1 reference

7 December 2017

I Jabbal-Gill

1

1 reference

7 December 2017

W Lin

2

1 reference

7 December 2017

P Jenkins

3

1 reference

7 December 2017

P Watts

4

1 reference

7 December 2017

M Jimenez

5

1 reference

7 December 2017

L Illum

6

1 reference

7 December 2017

S S Davis

7

1 reference

7 December 2017

J M Wood

8

1 reference

7 December 2017

D Major

9

1 reference

7 December 2017

P D Minor

10

1 reference

7 December 2017

X Li

11

1 reference

7 December 2017

E C Lavelle

12

1 reference

7 December 2017

A G Coombes

13

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

7 December 2017

number of pages

13

1 reference

inferred from page(s)

published in

Vaccine

1 reference

7 December 2017

volume

18

1 reference

7 December 2017

issue

3-4

1 reference

7 December 2017

page(s)

238-250

1 reference

Immunopotentiation and delivery systems for antigens for single-step immunization: recent trends and progress

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Adjuvants for human vaccines--current status, problems and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Immune responses to epitopes inserted in Salmonella flagellin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Controlled release microparticles as a single dose diphtheria toxoid vaccine: immunogenicity in small animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Mucosal immunogenicity elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly (D,L-lactide-co-glycolide) microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

1 reference

7 January 2021

Mucosal vaccines for the prevention of influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Immune responses in serum and respiratory secretions following vaccination with a live cold-recombinant (CR35) and inactivated A/USSR/77 (H1N1) influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Controlled-release vaccines--biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Potential of polymer microencapsulation technology for vaccine innovation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Aspects of the Design and Delivery of Microparticles for Vaccine Applications

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Resorbable synthetic polymers as replacements for bone graft

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

In vitro biocompatibility of bioresorbable polymers: poly(L, DL-lactide) and poly(L-lactide-co-glycolide).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Biodegradable microspheres as a vaccine delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

The distribution of protein associated with poly(DL-lactide co-glycolide) microparticles and its degradation in simulated body fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Resorbable lamellar particles of polylactide as adjuvants for influenza virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Protein adsorption to polymer particles: role of surface properties

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Adsorption of gamma-globulin, a model protein for antibody, on colloidal particles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Predicting the adsorption of proteins by aluminium-containing adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Contribution of electrostatic and hydrophobic interactions to the adsorption of proteins by aluminium-containing adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

B-cell memory is short-lived in the absence of antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Parameters affecting the immunogenicity of microencapsulated tetanus toxoid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Adjuvants: current status, clinical perspectives and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Assembly and intracellular transport of major histocompatibility complex molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Delivery of protein antigen to the major histocompatibility complex class I-restricted antigen presentation pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Adjuvants--a balance between toxicity and adjuvanticity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Cellular events in the mechanisms of prosthesis loosening

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Tissue response to implanted polymers: The significance of sample shape

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Microparticles as potentially orally active immunological adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

Poly(butyl-2-cyanoacrylate) particles as adjuvants for oral immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900195-4

7 January 2021

10.1016/S0264-410X(99)00195-4

Identifiers

DOI

1 reference

7 December 2017

1 reference